Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 94.4 EUR 0.38% Market Closed
Market Cap: 118.3B EUR
Have any thoughts about
Sanofi SA?
Write Note

Relative Value

The Relative Value of one SAN stock under the Base Case scenario is 132.14 EUR. Compared to the current market price of 94.4 EUR, Sanofi SA is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SAN Relative Value
Base Case
132.14 EUR
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
58
Median 3Y
2.6
Median 5Y
2.6
Industry
2.6
Forward
2.5
vs History
53
vs Industry
33
Median 3Y
17.6
Median 5Y
17.6
Industry
23
Forward
12.2
vs History
6
vs Industry
33
Median 3Y
11.4
Median 5Y
12
Industry
17.8
vs History
68
vs Industry
16
Median 3Y
19.7
Median 5Y
20.6
Industry
25.4
vs History
46
vs Industry
47
Median 3Y
1.6
Median 5Y
1.6
Industry
2.2
vs History
98
vs Industry
55
Median 3Y
2.8
Median 5Y
2.8
Industry
2.8
Forward
2.6
vs History
98
vs Industry
65
Median 3Y
4
Median 5Y
4.1
Industry
5.4
vs History
98
vs Industry
43
Median 3Y
8.7
Median 5Y
8.6
Industry
13.7
Forward
9
vs History
98
vs Industry
40
Median 3Y
12.7
Median 5Y
13.2
Industry
17.2
Forward
10.9
vs History
9
vs Industry
32
Median 3Y
12.3
Median 5Y
12.8
Industry
16.5
vs History
6
vs Industry
22
Median 3Y
16.2
Median 5Y
16.7
Industry
19.3
vs History
74
vs Industry
50
Median 3Y
1.1
Median 5Y
1.1
Industry
2

Multiples Across Competitors

SAN Competitors Multiples
Sanofi SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Sanofi SA
PAR:SAN
118.1B EUR 1.9 16.8 6.8 9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
FR
Sanofi SA
PAR:SAN
Average P/E: 31.2
16.8
121%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top